{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:17:21Z","timestamp":1785453441408,"version":"3.56.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"publisher","award":["WXLH202405010"],"award-info":[{"award-number":["WXLH202405010"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune checkpoint inhibitors (ICIs) represent a promising approach in tumor therapy. However, when applied to solid tumors\u2014the predominant form of tumors\u2014their efficacy is often constrained by the distinctive tumor microenvironment, yielding low response rates and resistance. Additionally, treatment with ICIs commonly leads to immune-related adverse events (irAEs). These challenges have restricted the broader clinical application of ICIs, underscoring the need for strategies that can enhance their antitumor effects while maintaining a favorable safety profile. Traditional Chinese medicine (TCM) is characterized by holistic regulation and has the therapeutic advantages of multi-level, multi-target and low toxicity. In recent years, it has shown great potential in addressing ICIs-related limitations. This review systematically summarizes current advances in the combined use of TCM and ICIs for solid tumors, aiming to offer new perspectives for incorporating TCM into future cancer treatment strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1723860","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:42:45Z","timestamp":1769755365000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress on traditional Chinese medicine-assisted immune checkpoint inhibitors therapy for solid tumors"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhipeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113365","DOI":"10.1016\/j.intimp.2024.113365","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2023.05.043","article-title":"Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery","volume":"166","author":"Wang","year":"2023","journal-title":"Acta Biomater"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030320","article-title":"Immune checkpoint inhibitors in non-small cell lung cancer: progress, challenges, and prospects","volume":"11","author":"Tang","year":"2022","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1200\/JCO.18.01042","article-title":"First-line nivolumab plus ipilimumab in advanced non-small-cell lung cancer (CheckMate 568): outcomes by programmed death ligand 1 and tumor mutational burden as biomarkers","volume":"37","author":"Ready","year":"2019","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e70324","DOI":"10.1002\/cam4.7032","article-title":"Safety and efficacy of rechallenge with immune checkpoint inhibitors in advanced solid tumor: A systematic review and meta-analysis","volume":"13","author":"Xu","year":"2024","journal-title":"Cancer Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12906-017-1626-2","article-title":"Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats","volume":"17","author":"Yuan","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1353325","article-title":"Traditional Chinese medicine Zhusha Anshen Wan: protective effects on liver, kidney, and intestine of the individual drugs using (1)H NMR metabolomics","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107650","DOI":"10.1016\/j.phrs.2025.107650","article-title":"Quality and composition control of complex TCM preparations through a novel \u201cHerbs-in vivo Compounds-Targets-Pathways\u201d network methodology: The case of Lianhuaqingwen capsules","volume":"213","author":"Chen","year":"2025","journal-title":"Pharmacol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1605330","article-title":"In vitro technology and ADMET research in traditional Chinese medicine","volume":"16","author":"Xue","year":"2025","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"118955","DOI":"10.1016\/j.jep.2024.118955","article-title":"Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: A mechanism discussion","volume":"338","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2236","article-title":"Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination","volume":"169","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00244-8","article-title":"CD28 as a molecular amplifier extending TCR ligation and signaling capabilities","volume":"15","author":"Michel","year":"2001","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","article-title":"CD28 and CTLA-4 coreceptor expression and signal transduction","volume":"229","author":"Rudd","year":"2009","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00995","article-title":"Five-year outcomes with nivolumab in patients with wild-type BRAF advanced melanoma","volume":"38","author":"Robert","year":"2020","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.06.034","article-title":"Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial","volume":"101","author":"Carlino","year":"2018","journal-title":"Eur J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","article-title":"Systematic review of medical treatment in melanoma: current status and future prospects","volume":"16","author":"Garbe","year":"2011","journal-title":"Oncologist"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"SChadendorf","year":"2015","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3145","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III\/IV melanoma: 5-year efficacy and biomarker results from checkMate 238","volume":"29","author":"Larkin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02498-y","article-title":"Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial","volume":"29","author":"VanderWalde","year":"2023","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1016\/j.cell.2021.05.027","article-title":"Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop","volume":"184","author":"Marangoni","year":"2021","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1200\/JCO.19.01307","article-title":"Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: A randomized, double-blind, phase III trial","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1709344","article-title":"Immune checkpoint inhibitors and endocrine side effects, a narrative review","volume":"132","author":"Agrawal","year":"2020","journal-title":"Postgrad Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112547","article-title":"Emerging ocular side effects of immune checkpoint inhibitors: A comprehensive review","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054422","article-title":"Tumor vasculature as an emerging pharmacological target to promote anti-tumor immunity","volume":"24","author":"Tzeng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"154787","DOI":"10.1016\/j.phymed.2023.154787","article-title":"Panax notoginseng saponins normalises tumour blood vessels by inhibiting EphA2 gene expression to modulate the tumour microenvironment of breast cancer","volume":"114","author":"Xia","year":"2023","journal-title":"Phytomedicine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.02.003","article-title":"Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery","volume":"14","author":"Qian","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B37","doi-asserted-by":"publisher","first-page":"155191","DOI":"10.1016\/j.phymed.2023.155191","article-title":"Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1","volume":"123","author":"Mao","year":"2024","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"106333","DOI":"10.1016\/j.phrs.2022.106333","article-title":"Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy","volume":"182","author":"Qian","year":"2022","journal-title":"Pharmacol Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"107032","DOI":"10.1016\/j.phrs.2023.107032","article-title":"Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives","volume":"199","author":"Wang","year":"2024","journal-title":"Pharmacol Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.762654","article-title":"Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases","volume":"12","author":"Ai","year":"2021","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"156562","DOI":"10.1016\/j.phymed.2025.156562","article-title":"Astragali Radix-Curcumae Rhizoma normalizes tumor blood vessels by HIF-1\u03b1 to anti-tumor metastasis in colon cancer","volume":"140","author":"Liang","year":"2025","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"155995","DOI":"10.1016\/j.phymed.2024.155995","article-title":"Taohong Siwu decoction enhances the chemotherapeutic efficacy of doxorubicin by promoting tumor vascular normalization","volume":"134","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"217094","DOI":"10.1016\/j.canlet.2024.217094","article-title":"Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer","volume":"598","author":"Wan","year":"2024","journal-title":"Cancer Lett"},{"key":"B45","doi-asserted-by":"publisher","first-page":"15347354231198195","DOI":"10.1177\/15347354231198195","article-title":"Effect of moxibustion combined with cisplatin on tumor microenvironment hypoxia and vascular normalization in lewis lung cancer mice","volume":"22","author":"Mao","year":"2023","journal-title":"Integr Cancer Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092687","article-title":"Cancer-associated fibroblast mediated inhibition of CD8+ Cytotoxic T cell accumulation in tumours: mechanisms and therapeutic opportunities","volume":"12","author":"Freeman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007447","article-title":"Targeting integrin \u03b15 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition","volume":"11","author":"Lu","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","article-title":"Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-\u03b2-induced epithelial-mesenchymal transition via directly targeting TGF\u03b2R1","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B52","doi-asserted-by":"publisher","first-page":"119907","DOI":"10.1016\/j.biomaterials.2020.119907","article-title":"Sequential delivery of nanoformulated \u03b1-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer","volume":"241","author":"Feng","year":"2020","journal-title":"Biomaterials"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c23166","article-title":"Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system","volume":"14","author":"Duan","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J Adv Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.319119","article-title":"Extracellular matrix stiffness regulates microvascular stability by controlling endothelial paracrine signaling to determine pericyte fate","volume":"43","author":"Yu","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/1535-7163.MCT-22-0595","article-title":"Interplay between extracellular matrix remodeling and angiogenesis in tumor ecosystem","volume":"22","author":"Siddhartha","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn0904","article-title":"Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies","volume":"16","author":"Lu","year":"2024","journal-title":"Sci Transl Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16556","article-title":"HIF-1\u03b1 is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov"},{"key":"B60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/2326-6066.CIR-23-0350","article-title":"Bexmarilimab activates human tumor-associated macrophages to support adaptive immune responses in interferon-poor immune microenvironments","volume":"12","author":"Rannikko","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001650","article-title":"4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39(+) CD8 T cells from primary and metastatic sites of epithelial ovarian cancers","volume":"8","author":"Leem","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hep.32335","article-title":"Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway","volume":"77","author":"Ma","year":"2023","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"154672","DOI":"10.1016\/j.phymed.2023.154672","article-title":"Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a\/STAT3\/IL-6R feedback loop, and modifies antitumor immunity","volume":"111","author":"Han","year":"2023","journal-title":"Phytomedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"116948","DOI":"10.1016\/j.jep.2023.116948","article-title":"Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4\/MyD88\/NF-\u03baB pathway","volume":"318","author":"Zhao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"117399","DOI":"10.1016\/j.jep.2023.117399","article-title":"Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12\/JAK2\/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer","volume":"320","author":"Kong","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/jca.88854","article-title":"Shenling Baizhu Decoction (SLBZD) may play a synergistic role of tirelizumab in the treatment of colorectal cancer by influencing the imbalance of colon flora and Tumor microenvironment","volume":"15","author":"Deng","year":"2024","journal-title":"J Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"112948","DOI":"10.1016\/j.yexcr.2021.112948","article-title":"Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo","volume":"410","author":"Sha","year":"2022","journal-title":"Exp Cell Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"106988","DOI":"10.1016\/j.phrs.2023.106988","article-title":"Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8(+) T cells via increasing intratumoral CXCL10","volume":"198","author":"Huang","year":"2023","journal-title":"Pharmacol Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-23-0309","article-title":"Combination of anti-PD-1 and electroacupuncture induces a potent antitumor immune response in microsatellite-stable colorectal cancer","volume":"12","author":"Wang","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"156968","DOI":"10.1016\/j.phymed.2025.156968","article-title":"Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China","volume":"145","author":"Lu","year":"2025","journal-title":"Phytomedicine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1391724","article-title":"Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis","volume":"14","author":"Shen","year":"2024","journal-title":"Front Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"15347354231226108","DOI":"10.1177\/15347354231226108","article-title":"Clinical experience of external application of clearing heat and removing dampness in relieving grade 2 to 3 rash caused by programed cell death protein 1 (PD-1)\/programed cell death ligand 1 (PD-L1) inhibitors: A single-center retrospective study","volume":"23","author":"Chen","year":"2024","journal-title":"Integr Cancer Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e2207786","DOI":"10.1002\/smll.202207786","article-title":"Normalization of tumor vessels by lenvatinib-based metallo-nanodrugs alleviates hypoxia and enhances calreticulin-mediated immune responses in orthotopic HCC and organoids","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908626116","article-title":"Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells","volume":"116","author":"Tian","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01569-z","article-title":"LAG-3 as the third checkpoint inhibitor","volume":"24","author":"Aggarwal","year":"2023","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011080","article-title":"Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer","volume":"13","author":"Yu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S0254-6272(18)30980-4","article-title":"Tanshinone II improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1\u20136 hepatoma mice model","volume":"38","author":"Zhang","year":"2018","journal-title":"J Tradit Chin Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1189532","article-title":"Tanshinone IIA promotes vascular normalization and boosts Sorafenib's anti-hepatoma activity via modulating the PI3K-AKT pathway","volume":"14","author":"Qin","year":"2023","journal-title":"Front Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"119966","DOI":"10.1016\/j.jep.2025.119966","article-title":"Astragalus injection antagonizes the efficacy of anti-PD-1 against melanoma through down-regulating MHC-II expression","volume":"349","author":"Lei","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.05.073","article-title":"Astragalus membranaceus polysaccharides potentiate the growth-inhibitory activity of immune checkpoint inhibitors against pulmonary metastatic melanoma in mice","volume":"182","author":"Hwang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00126839-200304010-00001","article-title":"Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook","volume":"4","author":"Qiu","year":"2003","journal-title":"f. Drugs R D"},{"key":"B83","doi-asserted-by":"publisher","first-page":"154097","DOI":"10.1016\/j.phymed.2022.154097","article-title":"Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90\u03b1, and RXR\u03b1","volume":"101","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2010.05.017","article-title":"Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways","volume":"640","author":"Li","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.122.001131","article-title":"Activation\/inactivation of anticancer drugs by CYP3A4: influencing factors for personalized cancer therapy","volume":"51","author":"Wang","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"B86","doi-asserted-by":"publisher","first-page":"113583","DOI":"10.1016\/j.jpba.2020.113583","article-title":"Quality evaluation of Salvia miltiorrhiza from different geographical origins in China based on qualitative and quantitative saccharide mapping and chemometrics","volume":"191","author":"Zhu","year":"2020","journal-title":"J Pharm BioMed Anal"},{"key":"B87","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jfda.2018.02.004","article-title":"Effects of processing adjuvants on traditional Chinese herbs","volume":"26","author":"Chen","year":"2018","journal-title":"J Food Drug Anal"},{"key":"B88","doi-asserted-by":"publisher","first-page":"117006","DOI":"10.1016\/j.ejmech.2024.117006","article-title":"New vision for TCM quality control: Elemental fingerprints and key ingredient combination strategy for identification and evaluation of TCMs","volume":"281","author":"Li","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.32","article-title":"Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-\u03b3","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i12.1333","article-title":"Drug induced autoimmune hepatitis: An unfortunate case of herbal toxicity from Skullcap supplement: A case report","volume":"15","author":"Thakral","year":"2023","journal-title":"World J Hepatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"7037786","DOI":"10.1155\/2021\/7037786","article-title":"Targeting the ang2\/tie2 axis with tanshinone IIA elicits vascular normalization in ischemic injury and colon cancer","volume":"2021","author":"Zou","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1534735418824408","DOI":"10.1177\/1534735418824408","article-title":"Combination of astragali polysaccharide and curcumin improves the morphological structure of tumor vessels and induces tumor vascular normalization to inhibit the growth of hepatocellular carcinoma","volume":"18","author":"Tang","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"B93","doi-asserted-by":"publisher","first-page":"116938","DOI":"10.1016\/j.taap.2024.116938","article-title":"Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1\u03b1\/VEGF","volume":"486","author":"Song","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13046-019-1291-z","article-title":"6-Gingerol stabilized the p-VEGFR2\/VE-cadherin\/\u03b2-catenin\/actin complex promotes microvessel normalization and suppresses tumor progression","volume":"38","author":"Zhong","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"15347354241273962","DOI":"10.1177\/15347354241273962","article-title":"Chinese herbal compound xiaoliu pingyi recipe inhibits the growth of lung adenocarcinoma by regulating the tumor vascular microenvironment","volume":"23","author":"Yang","year":"2024","journal-title":"Integr Cancer Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"113770","DOI":"10.1016\/j.jep.2020.113770","article-title":"Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy","volume":"270","author":"Cheng","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"116191","DOI":"10.1016\/j.jep.2023.116191","article-title":"Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK\/integrin signaling pathway","volume":"308","author":"Fu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.941854","article-title":"Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"113988","DOI":"10.1016\/j.intimp.2024.113988","article-title":"Electroacupuncture normalized tumor vasculature by downregulating glyoxalase-1 to polarize tumor-associated macrophage to M1 phenotype in triple-negative breast cancer","volume":"147","author":"Qi","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1186\/s12885-025-14629-4","article-title":"Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study","volume":"25","author":"Ko","year":"2025","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1723860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:42:47Z","timestamp":1769755367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1723860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2026.1723860"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1723860","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1723860"}}